Login to Your Account


Avoralstat fails to gel, but trial may rock solid form

Less than a month after Shire plc finished its $5.9 billion buyout of kallikrein player Dyax Corp., Biocryst Pharmaceuticals Inc.'s unhappy phase IIb data with an oral, liquid-filled soft-gel candidate avoralstat in the same class for HAE hobbled the firm on Wall Street.

more »


Our Habitat for All Things Science
WHO declares Zika an international emergency as IVD makers deliver 1st tests

PARIS – With increasing reports of neurological disorders and neonatal malformations caused by the Zika virus from 22 countries, the World Health Organization (WHO) has declared an international emergency, calling it an “extraordinary event.”

The WHO estimated there could be up to 4 million cases of Zika in the Americas in the next year, but no recommendations were made to restrict travel or trade. The WHO alert puts Zika in the same category of concern as Ebola.

READ MORE »

Opinion


Partners in Focus